Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR)
CUSIP: 12233L206
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
- Shares outstanding
- 9,041,375
- Total 13F shares
- 1,445,762
- Share change
- -758,884
- Total reported value
- $4,571,204
- Price per share
- $3.16
- Number of holders
- 17
- Value change
- -$2,836,549
- Number of buys
- 3
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 12233L206?
CUSIP 12233L206 identifies BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 12233L206:
Top shareholders of BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP |
13F
|
Company |
11%
|
994,883
|
$4,379,688 | — | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
4.1%
|
368,999
|
$1,660,458 | — | 31 Mar 2025 | |
| FIL Ltd |
13F
|
Company |
3.1%
|
280,898
|
$1,179,772 | — | 31 Mar 2025 | |
| CRCM LP |
13F
|
Company |
2.5%
|
226,290
|
$1,018,283 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
140,715
|
$591,003 | — | 31 Mar 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.49%
|
43,928
|
$197,672 | — | 31 Mar 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.49%
|
43,928
|
$184,058 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
31,717
|
$142,724 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.32%
|
29,296
|
$131,802 | — | 31 Mar 2025 | |
| HSG Holding Ltd |
13F
|
Company |
0.23%
|
21,212
|
$62,363 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
10,726
|
$48,265 | — | 31 Mar 2025 | |
| SkyView Investment Advisors, LLC |
13F
|
Company |
0.11%
|
10,000
|
$45,000 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
800
|
$3,600 | — | 31 Mar 2025 | |
| Neil Nanpeng Shen |
13F
|
Individual |
0.01%
|
885
|
$2,602 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
120
|
$504 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
110
|
$495 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
29
|
$121 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
10
|
$45 | — | 31 Mar 2025 |
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) as of Q2 2025
As of 30 Jun 2025,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,445,762 shares.
The largest 10 holders included
Kynam Capital Management, LP, CRCM LP, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., RENAISSANCE TECHNOLOGIES LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, BANK OF AMERICA CORP /DE/, CITADEL ADVISORS LLC, HSG Holding Ltd, and MORGAN STANLEY.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
18
Q2 2025 holders
17
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.